# Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT

> **NCT05095532** · PHASE1 · RECRUITING · sponsor: **Medical University of South Carolina** · enrollment: 42 (estimated)

## Conditions studied

- Chronic Pancreatitis
- Mesenchymal Stem Cells

## Interventions

- **BIOLOGICAL:** Bone marrow-derived mesenchymal stem cells
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05095532
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05095532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05095532, "Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05095532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*